Clinical utility of a next generation sequencing-based “oncochip” for therapeutic decision in metastatic breast cancer. Study SHARP
Latest Information Update: 08 Mar 2022
At a glance
- Drugs Bicalutamide (Primary) ; Olaparib (Primary) ; Selumetinib (Primary)
- Indications Adenocarcinoma; Advanced breast cancer
- Focus Therapeutic Use
- Acronyms SHARP
Most Recent Events
- 08 Mar 2022 New trial record